3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
141
Lung Neoplasms
51
Pancreatic Neoplasms
30
Non-Squamous Non-Small Cell Lung Cancer
18
Neoplasms
15
Adenocarcinoma of Lung
14
Head and Neck Neoplasms
13
Glioblastoma
13
Gliosarcoma
12
Breast Neoplasms
11
Brain Neoplasms
11
Neoplasm Metastasis
9
Carcinoma, Hepatocellular
9
Adenocarcinoma, Bronchiolo-Alveolar
9
Squamous Cell Carcinoma of Head and Neck
8
Carcinoma, Squamous Cell
7
Carcinoma, Renal Cell
7
Astrocytoma
6
Oligodendroglioma
5
Carcinoma
5
Urinary Bladder Neoplasms
4
Liver Neoplasms
4
Glioma
4
Esophageal Neoplasms
4
Colorectal Neoplasms
4
Adenocarcinoma
4
Recurrence
3
Rectal Neoplasms
3
Prostatic Neoplasms
3
Ovarian Neoplasms
3
Interventions
Bortezomib
3
fludarabine
2
Tacrolimus
2
Cyclophosphamide
2
ofatumumab
1
fludarabine phosphate
1
daratumumab
1
birtamimab
1
Zoledronic Acid
1
Whole-Body Irradiation
1
Vorinostat
1
Thalidomide
1
Stem Cell Transplantation
1
Plasma Exchange
1
Mycophenolic Acid
1
Melphalan
1
Lenalidomide
1
KW-2478
1
Hsp90 inhibitor KU757
1
Etoposide
1
Doxorubicin
1
Dexamethasone
1
Denosumab
1
Cisplatin
1
Calcium Dobesilate
1
Busulfan
1
Alemtuzumab
1
ARQ 197
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Paraproteinemias
×
Erlotinib Hydrochloride
×
Clear all
No trials found.